Ahmed Benyoucef
Overview
Explore the profile of Ahmed Benyoucef including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brassart C, Coutte A, Wallet J, Meyer E, Benyoucef A, Mnif H, et al.
Cancer Radiother
. 2024 Nov;
28(8):657-666.
PMID: 39578137
Purpose: Trimodal therapy, an organ-sparing alternative, may be proposed for selected patients with muscle-invasive bladder cancer instead of radical cystectomy. In this multicentre retrospective study, we aimed to assess the...
2.
Gueiderikh A, Sarrade T, Kirova Y, De La Lande B, De Vathaire F, Auzac G, et al.
Front Oncol
. 2023 Jul;
13:1199043.
PMID: 37456251
Purpose: Radiation-induced lung injury (RILI) is strongly associated with various clinical conditions and dosimetric parameters. Former studies have led to reducing radiotherapy (RT) doses to the lung and have favored...
3.
Ghannam Y, Di Meglio A, Sarrade T, Jacquet A, Everhard S, Kirova Y, et al.
Eur J Cancer
. 2022 Nov;
177:143-153.
PMID: 36356418
Background: Fatigue is a common and disabling symptom after breast cancer (BC) treatment, significantly impacting patients' quality of life. We aimed to assess the impact of radiation therapy (RT) modalities...
4.
Allali S, Carton M, Sarrade T, Querel O, Jacquet A, Rivera S, et al.
Int J Cancer
. 2022 Apr;
151(7):1098-1108.
PMID: 35489021
Skin damage is the most common and most important toxicity during and after radiation therapy (RT). Its assessment and understanding of the factors influencing its occurrence, is a major issue...
5.
Bourgier C, Cowen D, Castan F, Lemanski C, Gourgou S, Rivera S, et al.
Radiother Oncol
. 2021 Sep;
164:57-65.
PMID: 34571090
Purpose: To describe the quality assurance (QA) program and early toxicities in the phase III randomized trial BONBIS (NCT00907868) on the role of a localized radiation boost in ductal carcinoma...
6.
Sargos P, Chabaud S, Latorzeff I, Magne N, Benyoucef A, Supiot S, et al.
Lancet Oncol
. 2020 Oct;
21(10):1341-1352.
PMID: 33002438
Background: Adjuvant radiotherapy reduces the risk of biochemical progression in prostate cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early salvage radiotherapy after radical prostatectomy, combined with...
7.
Tuech J, Gangloff A, Di Fiore F, Benyoucef A, Michel P, Schwarz L
Oncology
. 2020 Jul;
98(12):827-835.
PMID: 32683373
On March 11, 2020, the WHO director general declared COVID-19 a pandemic. This pandemic evolves in successive phases, i.e., phase 1 (the start phase), phase 2 ("the storm"), and phase...
8.
Mallet R, Modzelewski R, Lequesne J, Mihailescu S, Decazes P, Auvray H, et al.
Radiat Oncol
. 2020 May;
15(1):116.
PMID: 32443967
Background: Sarcopenia is defined by a loss of skeletal muscle mass with or without loss of fat mass. Sarcopenia has been associated to reduced tolerance to treatment and worse prognosis...
9.
Nkhali L, Thureau S, Edet-Sanson A, Doyeux K, Benyoucef A, Gardin I, et al.
Acta Oncol
. 2014 Nov;
54(6):909-15.
PMID: 25417733
Background: A planning study investigated whether reduced target volumes defined on FDG-PET/CT during radiotherapy allow total dose escalation without compromising normal tissue tolerance in patients with esophageal cancer. Material And...
10.
Vera P, DuBray B, Palie O, Buvat I, Hapdey S, Modzelewski R, et al.
EJNMMI Res
. 2014 Mar;
4(1):12.
PMID: 24602385
Background: The objective of this study is to investigate the feasibility and the additional interest of a parametric imaging (PI) method to monitor the early tumour metabolic response in a...